HepC Micro-elimination on MSM and TGW Population.

Projecte dels NOMS Hispanosida

Status: Completed

Conditions: Hepatitis C; PrEP; Drugs of Abuse

Study type: Observational

Funder types: Other

Identifiers

NCT06847958

MSM-HCV-MicroElimination

PI-21-206 (Registry Identifier)

IN-ES-987-5997 (Other Grant/Funding Number)

Details and patient eligibility

About

This is an observational study, in which a single visit will be carried out, which includes a questionnaire on sexual habits and in which the possibility of carrying out a screening for Hepatitis C will be offered. Depending on the score obtained in the questionnaire, the screening will be carried out using a rapid serology test or viral load. During the first year, a SCORE will be developed to classify the risk of positive results. This SCORE will be used during phase 2 to offer users of the centres a targeted screening based on the Pre-test score.

Enrollment: 13,161 patients

Sex: Male

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. All BCN Checkpoint and BCN PreP·Point clients.
2. 18 years and older.
3. HIV uninfected or diagnosticated in the center in the last 7 days prior to the study inclusion.
4. Men that have sex with men or transgender women.
5. Signature of written consent form.
6. Ability to comply with the requirements of the study protocol.

Exclusion criteria

1. Knowledge of HIV infection from more than 7 days
2. Knowledge of active HCV infection

Trial design

13,161 participants in 2 patient groups

MSM and TGW HIV negative PrEP User.

MSM and TGW HIV negative non PrEP User.